HMGB1 and cancer: The pooled results demonstrated that HMGB1 rs1045411 polymorphism emerge as a risk factor for cancer, as a significant association between increased cancer risk and TT genotype was indicated in the comparison of the TT vs. CC+TC genotype (OR=1.35; 95% CI: 1.09-1.67; p=0.005).